bioAffinity Technologies to implement 1-for-30 reverse stock split
NeutralFinancial Markets

bioAffinity Technologies has announced a 1-for-30 reverse stock split, a move that aims to increase its stock price and attract more investors. This decision is significant as it reflects the company's strategy to enhance its market position and improve liquidity, which could ultimately benefit shareholders in the long run.
— Curated by the World Pulse Now AI Editorial System